A client with end-stage liver failure presents with confusion, lethargy, and asterixis. Which laboratory result is most likely associated with these symptoms?

Rationale: A. In end-stage liver failure, the liver’s ability to produce clotting factors and thrombopoietin is impaired. This often leads to thrombocytopenia (low platelet count) rather than elevated platelets. Low platelet counts can contribute to bleeding risks but are not related to neurological symptoms such as confusion or asterixis. An elevated platelet count would be unusual in this context and is not associated with hepatic encephalopathy. B. Albumin is a protein synthesized by the liver, and in end-stage liver disease, albumin production decreases, leading to hypoalbuminemia. Low albumin contributes to edema and ascites due to decreased oncotic pressure but does not cause confusion, lethargy, or asterixis. Normal albumin levels would be unexpected in severe liver failure and do not explain the neurological findings. C. Neurological symptoms such as confusion, lethargy, and asterixis (“flapping tremor” of the hands) are hallmark signs of hepatic encephalopathy. Hepatic encephalopathy occurs because the failing liver cannot effectively metabolize ammonia, a byproduct of protein metabolism. Elevated serum ammonia crosses the blood-brain barrier, leading to neurotoxicity, which manifests as cognitive changes and motor abnormalities. Although the severity of symptoms does not always directly correlate with ammonia levels, high ammonia is the most relevant laboratory indicator of hepatic encephalopathy in this scenario. D. Bilirubin, a product of hemoglobin breakdown processed by the liver, is usually elevated in liver failure, leading to jaundice. A decreased bilirubin level is not typical of liver failure and does not explain neurological symptoms such as confusion, lethargy, or asterixis.